Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PaSEM: Male Reproductive Safety of BPaMZ in Drug-Resistant TB
NCT04179500Phase 2Completed
- Sponsor
- TB Alliance
- Start
- Sep 2021
- Primary completion
- Jun 2023
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of pretomanid in pulmonary tuberculosis (TB), sponsored by TB Alliance. Primary endpoint: Change From Baseline Total Sperm Count at 26 weeks. Started Sep 2021; status: completed.
02
Drugs
pretomanid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT04179500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04179500.